UHS:NYE-Universal Health Services Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 201.69

Change

0.00 (0.00)%

Market Cap

USD 13.69B

Volume

0.76M

Analyst Target

USD 129.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 89.71B
THC Tenet Healthcare Corporation

N/A

USD 15.44B
DVA DaVita HealthCare Partners Inc

N/A

USD 11.58B
EHC Encompass Health Corp

N/A

USD 10.27B
CHE Chemed Corp

N/A

USD 7.97B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 2.08B
BKD Brookdale Senior Living Inc

N/A

USD 1.04B
AMN AMN Healthcare Services Inc

N/A

USD 0.90B

ETFs Containing UHS

XLVE:CA Mulvihill U.S. Health Car.. 1.94 % 0.00 %

N/A

N/A
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.18 % 0.00 %

N/A

N/A
JPGL:F JPmorgan ETFs Ireland Ica.. 0.35 % 0.00 %

N/A

USD 0.22B
JPGL:SW JPM Global Equity Multi-F.. 0.35 % 0.00 %

N/A

N/A
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 0.01B
RNMC 0.00 % 0.60 %

N/A

N/A
ENG:PA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

USD 0.24B
XU61:F BNP Paribas Easy SICAV - .. 0.00 % 0.00 %

N/A

USD 0.24B
XU61:XETRA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

USD 0.27B
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

USD 0.22B
JPGL:LSE JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

USD 0.18B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.31% 65% D 88% B+
Dividend Return 0.39% 22% F 5% F
Total Return 32.70% 65% D 87% B+
Trailing 12 Months  
Capital Gain 48.35% 65% D 89% A-
Dividend Return 0.59% 22% F 6% D-
Total Return 48.93% 65% D 88% B+
Trailing 5 Years  
Capital Gain 42.28% 67% D+ 67% D+
Dividend Return 2.40% 29% F 6% D-
Total Return 44.67% 67% D+ 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.83% 48% F 70% C-
Dividend Return 12.34% 48% F 66% D+
Total Return 0.51% 22% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 30.77% 74% C 35% F
Risk Adjusted Return 40.09% 65% D 57% F
Market Capitalization 13.69B 90% A- 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.